PTJ
MRVI icon

Paul Tudor Jones’s Maravai LifeSciences MRVI Stock Holding History

Paul Tudor Jones’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Buy
1,849,079
+1,452,164
+366% +$6.27M 0.02% 752
2026
Q1 		$1.12M Buy
+396,915
New +$1.35M ﹤0.01% 2281
2021
Q1 		– Sell
-174,735
Closed -$4.9M – 1748
2020
Q4 		$4.9M Buy
+174,735
New +$4.87M 0.14% 145

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Paul Tudor Jones's MRVI Position: Q2 2026 in Review

Paul Tudor Jones increased its Maravai LifeSciences (MRVI) stake by 366% in Q2 2026, buying an estimated $6.27M and bringing the position to 1,849,079 shares worth $11.5M. The position accounts for 0.02% of the portfolio, ranked #752.

Paul Tudor Jones first reported a position in MRVI in Q4 2020 and has held it in 3 quarters since. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Paul Tudor Jones held 1,849,079 shares of Maravai LifeSciences worth $11.5M as of Q2 2026.
  • Paul Tudor Jones bought 1,452,164 Maravai LifeSciences shares in Q2 2026, an estimated $6.27M.
  • Maravai LifeSciences made up 0.02% of Paul Tudor Jones's portfolio in Q2 2026, its #752 holding.
  • Paul Tudor Jones first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 3 quarters since.
  • 177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.